Advertisements


Mylan to have only a "minor" delay to generic Advair approval, says BMO Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Even minor delays can hurt Mylan"s generic Advair opportunity, says Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 25th, 2018

Mylan (MYL) to Get CRL Again for Generic Advair from FDA

Mylan (MYL) suffers another setback with its ANDA for Advair as the FDA refuses to approve the same, due to minor deficiencies. Shares of Myla.....»»

Category: smallbizSource: nytJun 14th, 2018

Technical Take: Mylan falls after FDA says generic Advair has minor deficiencies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Advair generic delay negative news for Mylan, says Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Morgan Stanley says generic Advair delay a small negative for Mylan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Mylan to recover from "modest" generic Advair delay, says Mizuho

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Mylan falls 4.5% after FDA says generic Advair Diskus has minor deficiencies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

FDA says Mylan"s generic Advair Diskus has minor deficiencies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Trade deal with Canada, Mexico could delay arrival of cheaper generic drugs, critics warn

Market protections granted to makers of expensive brand-name drugs could complicate efforts to win congressional approval Canada, Mexico.....»»

Category: topSource: usatodayDec 27th, 2018

Akorn gets FDA approval for generic Voltaren Gel, says RBC Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 26th, 2018

With Mylan"s Neulasta Biosimilar Approval, Focus Moves To Advair And Restasis

With Mylan"s Neulasta Biosimilar Approval, Focus Moves To Advair And Restasis.....»»

Category: topSource: seekingalphaJun 13th, 2018

Biocon 483 letter won"t delay approval of Mylan"s Neulasta, says Bernstein

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 18th, 2018

Einhorn"s Greenlight sells some positions, covers prominent shorts

Hedge fund manager David Einhorn, whose Greenlight Capital suffered its worst year ever in 2018, told investors that he had made some changes to the portfolio, including selling Bayer , Mylan and Perrigo last year......»»

Category: topSource: reuters5 hr. 50 min. ago

Greenlight"s Einhorn tweaks portfolio, says CFO to leave

Hedge fund manager David Einhorn, whose Greenlight Capital suffered its worst year ever in 2018, told investors on Wednesday he had made some changes to the fund's main portfolio, including selling Bayer , Mylan and Perrigo last year......»»

Category: topSource: reuters5 hr. 50 min. ago

BlueMountain Pushes Back Again Over PG&E"s Bankruptcy Plan

Stock in the California utility PG&E was surging Tuesday afternoon, after another plea from BlueMountain Capital to delay a Chapter 11 bankruptcy filing......»»

Category: topSource: barrons16 hr. 49 min. ago

BofA Gives Seal Of Approval To GE Divestitures, Stays Neutral On Stock

General Electric Company (NYSE: GE) move to divest more GE Capital Assets with the sale of supply chain finance unit Trade Payable Services is a solid step, according to Bank of America Merrill Lynch.  .....»»

Category: blogSource: benzingaJan 17th, 2019

Teva receives FDA approval for generic version of Sabril

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 16th, 2019

Amneal Pharmaceuticals receives FDA approval for generic version of Exelon Patch

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 14th, 2019

U.S. government says shutdown may slow resolution of CVS/Aetna court process

The Justice Department has said in a court filing that a partial government shutdown could delay its response to comments on pharmacy chain CVS Health Corp's purchase of health insurer Aetna, a necessary step in a court giving final approval to the deal......»»

Category: topSource: reutersJan 9th, 2019

Dayton Power & Light seeks approval for $576M grid plan

Dayton Power and Light Co. is proposing $576 million in capital projects over the next decade to transform its electric grid. The proposals will allow DP&L to prepare for the integration of electric vehicle charging infrastructure and distributed energy .....»»

Category: topSource: bizjournalsDec 31st, 2018